Literature DB >> 15701808

Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.

R A Bryan1, O Zaragoza, T Zhang, G Ortiz, A Casadevall, E Dadachova.   

Abstract

The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans is an important virulence factor, but relatively little is known about its architecture. We applied a combination of radiological, chemical, and serological methods to investigate the structure of this polysaccharide capsule. Exposure of C. neoformans cells to gamma radiation, dimethyl sulfoxide, or radiolabeled monoclonal antibody removed a significant part of the capsule. Short intervals of gamma irradiation removed the outer portion of the cryptococcal capsule without killing cells, which could subsequently repair their capsules. Survival analysis of irradiated wild-type, acapsular mutant, and complemented mutant strains demonstrated that the capsule contributed to radioprotection and had a linear attenuation coefficient higher than that of lead. The capsule portions remaining after dimethyl sulfoxide or gamma radiation treatment were comparable in size, 65 to 66 microm3, and retained immunoreactivity for a monoclonal antibody to glucuronoxylomannan. Simultaneous or sequential treatment of the cells with dimethyl sulfoxide and radiation removed the remaining capsule so that it was not visible by light microscopy. The capsule could be protected against radiation by either of the free radical scavengers ascorbic acid and sorbitol. Sugar composition analysis of polysaccharide removed from the outer and inner parts of the capsule revealed significant differences in glucuronic acid and xylose molar ratios, implying differences in the chemical structure of the constituent polysaccharides. Our results provide compelling evidence for the existence of two zones in the C. neoformans capsule that differ in susceptibility to dimethyl sulfoxide and radiation and, possibly, in packing and composition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701808      PMCID: PMC549344          DOI: 10.1128/EC.4.2.465-475.2005

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  33 in total

1.  Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule.

Authors:  Amy J Reese; Tamara L Doering
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

Review 2.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

3.  Large Cryptococcus neoformans isolated from brain abscess.

Authors:  G L Love; G D Boyd; D L Greer
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

4.  Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans.

Authors:  J Mukherjee; W Cleare; A Casadevall
Journal:  J Immunol Methods       Date:  1995-07-17       Impact factor: 2.303

5.  Studies on capsule synthesis of Cryptococcus neoformans.

Authors:  F Bergman
Journal:  Sabouraudia       Date:  1965-02

6.  Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus.

Authors:  K B Lengeler; G M Cox; J Heitman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 7.  How does Cryptococcus get its coat?

Authors:  T L Doering
Journal:  Trends Microbiol       Date:  2000-12       Impact factor: 17.079

8.  Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.

Authors:  Javier García-Rivera; Yun C Chang; K J Kwon-Chung; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2004-04

Review 9.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Binding of cryptococcal polysaccharide to Cryptococcus neoformans.

Authors:  T R Kozel; C A Hermerath
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more
  54 in total

1.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

3.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Macrolides Inhibit Capsule Formation of Highly Virulent Cryptococcus gattii and Promote Innate Immune Susceptibility.

Authors:  Shigeki Nakamura; Yurika Ikeda-Dantsuji; Lianjin Jin; Yoshitsugu Higashi; Masahiro Abe; Tatsuya Inukai; Minoru Nagi; Makoto Urai; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

5.  Antibody-guided alpha radiation effectively damages fungal biofilms.

Authors:  L R Martinez; R A Bryan; C Apostolidis; A Morgenstern; A Casadevall; E Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

6.  Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans.

Authors:  Ruth A Bryan; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

7.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

Review 8.  Radioimmunotherapy of infectious diseases.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Semin Nucl Med       Date:  2009-03       Impact factor: 4.446

9.  Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences.

Authors:  Susana Frases; Leonardo Nimrichter; Nathan B Viana; Antonio Nakouzi; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-12-21

10.  Fungal cell gigantism during mammalian infection.

Authors:  Oscar Zaragoza; Rocío García-Rodas; Joshua D Nosanchuk; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.